Free Trial

WAVE Life Sciences (WVE) Short Interest Ratio & Short Volume

WAVE Life Sciences logo
$10.15 +0.39 (+4.00%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$10.22 +0.07 (+0.69%)
As of 08/22/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WAVE Life Sciences Short Interest Data

WAVE Life Sciences (WVE) has a short interest of 16.08 million shares, representing 13.29% of the float (the number of shares available for trading by the public). This marks a -2.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.8, indicating that it would take 11.8 days of the average trading volume of 1.65 million shares to cover all short positions.

Current Short Interest
16,080,000 shares
Previous Short Interest
16,410,000 shares
Change Vs. Previous Month
-2.01%
Dollar Volume Sold Short
$130.25 million
Short Interest Ratio
11.8 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
159,140,000 shares
Short Percent of Float
13.29%
Today's Trading Volume
2,247,207 shares
Average Trading Volume
1,645,441 shares
Today's Volume Vs. Average
137%
Short Selling WAVE Life Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for WAVE Life Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

WVE Short Interest Over Time

WVE Days to Cover Over Time

WVE Percentage of Float Shorted Over Time

WAVE Life Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202516,080,000 shares $130.25 million -2.0%13.3%11.8 $8.10
7/15/202516,410,000 shares $126.52 million -81.1%N/A11.5 $7.71
6/30/202586,630,000 shares $563.10 million +482.2%73.3%2 $6.50
6/15/202514,880,000 shares $103.42 million -1.0%13.5%10.3 $6.95
5/31/202515,030,000 shares $91.38 million -2.7%13.9%10.3 $6.08
5/15/202515,450,000 shares $97.34 million +16.7%14.3%10.4 $6.30
4/30/202513,240,000 shares $102.21 million +13.5%N/A9.3 $7.72
4/15/202511,670,000 shares $73.29 million +17.4%10.8%9.6 $6.28
3/31/20259,940,000 shares $80.32 million +19.2%9.2%8.6 $8.08
3/15/20258,340,000 shares $85.23 million -9.0%7.7%8.5 $10.22
2/28/20259,160,000 shares $96.82 million -4.0%8.5%9.3 $10.57
2/15/20259,540,000 shares $103.13 million +1.5%8.8%10.3 $10.81
1/31/20259,400,000 shares $108.76 million +9.1%N/A9.1 $11.57
1/15/20258,620,000 shares $98.87 million +5.0%N/A7.8 $11.47
12/31/20248,210,000 shares $101.56 million +16.5%N/A5.7 $12.37
12/15/20247,050,000 shares $94.75 million +1.7%N/A3.6 $13.44
11/30/20246,930,000 shares $104.64 million +7.4%N/A3.7 $15.10
11/15/20246,450,000 shares $88.17 million -5.4%N/A3.5 $13.67
10/31/20246,820,000 shares $93.50 million +39.5%N/A4 $13.71
10/15/20244,890,000 shares $41.86 million -12.5%N/A3.1 $8.56
9/30/20245,590,000 shares $45.84 million +58.4%N/A4.6 $8.20
9/15/20243,530,000 shares $20.69 million +4.4%N/A3.2 $5.86
8/31/20243,380,000 shares $19.40 million +0.9%N/A3.9 $5.74
8/15/20243,350,000 shares $19.46 million -6.9%N/A3.9 $5.81
7/31/20243,600,000 shares $23.80 million -7.2%N/A4.1 $6.61
7/15/20243,880,000 shares $23.24 million -19.2%N/A4.5 $5.99
6/30/20244,800,000 shares $23.95 million +53.9%N/A5.8 $4.99
6/15/20243,120,000 shares $19.44 million +23.3%N/A4.1 $6.23
5/31/20242,530,000 shares $15.64 million -8.7%N/A3.8 $6.18
5/15/20242,770,000 shares $16.34 million -0.4%N/A3.2 $5.90
4/30/20242,780,000 shares $13.71 million -11.8%N/A3.1 $4.93
4/15/20243,150,000 shares $18.08 million -12.3%N/A3.6 $5.74
3/31/20243,590,000 shares $22.15 million +19.7%N/A4 $6.17
3/15/20243,000,000 shares $19.50 million +0.7%N/A3.2 $6.50
2/29/20242,980,000 shares $14.33 million +18.7%N/A2.9 $4.81
2/15/20242,510,000 shares $9.46 million -15.2%N/A3 $3.77
1/31/20242,960,000 shares $12.79 million -8.1%N/A4.1 $4.32
1/15/20243,220,000 shares $16.10 million +1.3%N/A5 $5.00
12/31/20233,180,000 shares $16.06 million -0.6%N/A5.3 $5.05
12/15/20233,200,000 shares $14.11 million -1.8%N/A5.6 $4.41
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/30/20233,260,000 shares $17.31 million -6.3%N/A6.8 $5.31
11/15/20233,480,000 shares $18.90 million -3.1%N/A11.9 $5.43
10/31/20233,590,000 shares $19.31 million -2.7%N/A13.2 $5.38
10/15/20233,690,000 shares $20.48 million +3.4%N/A12.7 $5.55
9/30/20233,570,000 shares $20.53 million +4.4%N/A12.4 $5.75
9/15/20233,420,000 shares $18.47 million No ChangeN/A12.2 $5.40
8/31/20233,420,000 shares $14.88 million -6.0%N/A9.3 $4.35
8/15/20233,640,000 shares $16.09 million +5.5%N/A8.8 $4.42
7/31/20233,450,000 shares $15.08 million -2.8%N/A7.9 $4.37
7/15/20233,550,000 shares $14.34 million -1.1%N/A8 $4.04
6/30/20233,590,000 shares $13.07 million +112.4%N/A8.1 $3.64
6/15/20231,690,000 shares $6.61 million -5.1%N/A3.9 $3.91
5/31/20231,780,000 shares $7.05 million -19.5%N/A5 $3.96
5/15/20232,210,000 shares $8.91 million +13.3%N/A6.2 $4.03
4/30/20231,950,000 shares $7.78 million -0.5%N/A5.5 $3.99
4/15/20231,960,000 shares $8.80 million -3.0%N/A5.3 $4.49
3/31/20232,020,000 shares $8.75 million +32.0%N/A4.7 $4.33
3/15/20231,530,000 shares $6.10 million +36.6%N/A3.3 $3.99
2/28/20231,120,000 shares $4.70 million -11.8%N/A1.6 $4.20
2/15/20231,270,000 shares $5.52 million -22.1%N/A1.8 $4.35
1/31/20231,630,000 shares $8.04 million +6.5%N/A2.3 $4.93
1/15/20231,530,000 shares $8.35 million +2.0%N/A2.2 $5.46
12/30/20221,500,000 shares $10.50 million -23.1%N/A2.2 $7.00
12/15/20221,950,000 shares $10.51 million +32.7%N/A2.9 $5.39
11/30/20221,470,000 shares $6.23 million +2.8%N/A4.1 $4.24
11/15/20221,430,000 shares $4.55 million -1.4%N/A4.4 $3.18
10/31/20221,450,000 shares $6.95 million -8.2%N/A3.6 $4.79
10/15/20221,580,000 shares $8.22 million -11.2%N/A3.9 $5.20
9/30/20221,780,000 shares $6.43 million +19.5%N/A4.7 $3.61
9/15/20221,490,000 shares $5.01 million -0.7%N/A2.8 $3.36
8/31/20221,500,000 shares $4.46 million -9.1%N/A2.7 $2.97
8/15/20221,650,000 shares $5.78 million +10.0%N/A2.8 $3.50
7/31/20221,500,000 shares $3.81 million -20.6%N/A2.9 $2.54
7/15/20221,890,000 shares $7.16 million -21.6%N/A3.4 $3.79
6/30/20222,410,000 shares $7.83 million -50.9%N/A4.3 $3.25
6/15/20224,910,000 shares $10.75 million -1.0%9.9%9 $2.19
5/31/20224,960,000 shares $6.94 million +3.8%10.0%12.4 $1.40
5/15/20224,780,000 shares $5.88 million +11.7%9.7%11.7 $1.23
4/30/20224,280,000 shares $8.35 million +16.6%N/A10.9 $1.95
4/15/20223,670,000 shares $7.96 million +7.3%N/A10.5 $2.17
3/31/20223,420,000 shares $6.84 million +7.6%N/A10 $2.00
3/15/20223,180,000 shares $7.03 million +10.4%N/A10.4 $2.21
2/28/20222,880,000 shares $7.08 million +36.5%5.8%9 $2.46
2/15/20222,110,000 shares $5.28 million +47.6%4.3%6.7 $2.50
1/31/20221,430,000 shares $3.13 million +26.6%N/A4.6 $2.19
1/15/20221,130,000 shares $2.97 million -0.9%3.5%2.6 $2.63
12/31/20211,140,000 shares $3.58 million -0.9%N/A2.7 $3.14
12/15/20211,150,000 shares $3.89 million +8.5%3.6%2.5 $3.38
11/30/20211,060,000 shares $4.13 million -3.6%3.4%2.3 $3.90
11/15/20211,100,000 shares $4.97 million +13.6%3.5%2.3 $4.52
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
10/29/2021968,500 shares $4.45 million +7.6%3.1%2.1 $4.59
10/15/2021900,500 shares $4.64 million -28.5%2.6%2.4 $5.15
9/30/20211,260,000 shares $6.17 million -31.2%3.7%3 $4.90
9/15/20211,830,000 shares $10.14 million -9.9%5.4%4.6 $5.54
8/31/20212,030,000 shares $12.85 million -8.6%5.9%5.1 $6.33
8/13/20212,220,000 shares $14.23 million -3.5%6.5%4.9 $6.41
7/30/20212,300,000 shares $12.67 million -0.4%6.7%3.9 $5.51
7/15/20212,310,000 shares $14.97 million +6.0%6.8%3.5 $6.48
6/30/20212,180,000 shares $14.52 million +4.3%6.4%3.3 $6.66
6/15/20212,090,000 shares $14.90 million -29.6%6.1%2.3 $7.13
5/28/20212,970,000 shares $20.31 million -21.2%8.7%3.1 $6.84
5/14/20213,770,000 shares $22.09 million +6.2%11.1%3.8 $5.86
4/30/20213,550,000 shares $21.76 million +12.3%11.2%4 $6.13
4/15/20213,160,000 shares $19.78 million +9.3%10.3%3.8 $6.26
3/31/20212,890,000 shares $17.22 million -30.9%9.4%3.3 $5.96
3/15/20214,180,000 shares $41.51 million -15.0%13.6%6 $9.93
2/26/20214,920,000 shares $46.30 million +12.3%16.0%7.7 $9.41
2/12/20214,380,000 shares $47.26 million +2.3%14.2%7.1 $10.79
1/29/20214,280,000 shares $42.20 million -2.5%13.1%6.4 $9.86
1/15/20214,390,000 shares $39.38 million +10.0%14.2%6.1 $8.97
12/31/20203,990,000 shares $31.80 million +9.0%12.9%5.6 $7.97
12/15/20203,660,000 shares $33.71 million -5.4%11.8%4 $9.21
11/30/20203,870,000 shares $35.84 million -1.3%12.0%3.3 $9.26
10/30/20204,640,000 shares $33.87 million -9.2%14.3%3.7 $7.30
10/15/20205,110,000 shares $45.33 million -4.8%15.8%4.3 $8.87
9/30/20205,370,000 shares $45.59 million +12.3%17.1%4.8 $8.49
9/15/20204,780,000 shares $78.20 million No Change16.3%5.1 $16.36
8/31/20204,780,000 shares $59.89 million -3.0%16.3%8.4 $12.53

WVE Short Interest - Frequently Asked Questions

What is WAVE Life Sciences' current short interest?

Short interest is the volume of WAVE Life Sciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 16,080,000 shares of WVE short. 13.29% of WAVE Life Sciences' shares are currently sold short. Learn More on WAVE Life Sciences' current short interest.

What is a good short interest ratio for WAVE Life Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WVE shares currently have a short interest ratio of 12.0. Learn More on WAVE Life Sciences's short interest ratio.

Which institutional investors are shorting WAVE Life Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of WAVE Life Sciences: Group One Trading LLC, Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for WAVE Life Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.29% of WAVE Life Sciences' floating shares are currently sold short.

Is WAVE Life Sciences' short interest increasing or decreasing?

WAVE Life Sciences saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 16,080,000 shares, a decline of 2.0% from the previous total of 16,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does WAVE Life Sciences' short interest compare to its competitors?

13.29% of WAVE Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to WAVE Life Sciences: CRISPR Therapeutics AG (26.94%), Axsome Therapeutics, Inc. (9.47%), Nuvalent, Inc. (11.99%), Abivax SA Sponsored ADR (2.78%), Merus N.V. (6.44%), Cytokinetics, Incorporated (13.26%), Viking Therapeutics, Inc. (26.61%), TG Therapeutics, Inc. (16.53%), Krystal Biotech, Inc. (13.61%), ACADIA Pharmaceuticals Inc. (8.89%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short WAVE Life Sciences stock?

Short selling WVE is an investing strategy that aims to generate trading profit from WAVE Life Sciences as its price is falling. WVE shares are trading up $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against WAVE Life Sciences?

A short squeeze for WAVE Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WVE, which in turn drives the price of the stock up even further.

How often is WAVE Life Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WVE, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:WVE) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners